InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,743.61
(
0.37%
)
US TECH 100
19,570.40
(
0.71%
)
Dow Jones
42,177.80
(
0.63%
)
Brent Oil
71.00
(
-3.00%
)
Bitcoin
65,233.23
(
3.33%
)
Post# of 253235
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

turtlepower

Send PM Follow Ignore
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

turtlepower

Re: DewDiligence post# 97437

Friday, 10/08/2010 8:17:24 AM

Friday, October 08, 2010 8:17:24 AM

Post# of 253235
Boehringer Ends Female Desire Drug Development After FDA's Safety Query
By Naomi Kresge - Oct 8, 2010 3:55 AM ET
Tweet LinkedIn Share Print Email
Oct. 8 (Bloomberg) - Boehringer Ingelheim GmbH abandoned development of its female desire drug flibanserin after U.S. regulators said the pill wasn’t proven to be safe and effective.

<snip>
http://www.bloomberg.com/news/2010-10-08/boehringer-ends-female-desire-drug-development-after-fda-s-safety-query.html?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up